Covid-19 roundup: J&J charts swift path to 1B vac­cine dos­es; Em­bassy ca­ble spot­lights pos­si­ble Wuhan lab con­nec­tion to coro­n­avirus

J&J, the first large phar­ma­ceu­ti­cal com­pa­ny to un­veil its per­for­mance in the first quar­ter, ac­knowl­edged the coro­n­avirus pan­dem­ic has had a sharp im­pact across its full-year guid­ance and of­fered some fresh de­tails on its Covid-19 vac­cine in de­vel­op­ment.

J&J, like its peers, is at­tempt­ing to do in six to 12 months what usu­al­ly takes 5 to 7 years, CEO Alex Gorsky re­mind­ed an­a­lysts on a con­fer­ence call on Mon­day.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.